AndrewWilliamCampbellMD

PubMed

• 1 citations
  The Brain and Mycotoxins.
  Andrew W Campbell, Karen Decena> ;Alternative Therapies in Health and Medicine. 2020 Nov 1
• 1 citations
  Mold, Mycotoxins, and their Effects in Children.
  Andrew W Campbell, Peggy Watson> ;Alternative Therapies in Health and Medicine. 2021 Jan 1
• 2 citations
  Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled...
  Andrew W Campbell, Drew Sinatra, Zhiwei Zhang, Stephen T. Sinatra> ;Integrative Medicine. 2020 Apr 1
• Lyme Disease and Mycotoxicosis: How to Differentiate Between the Two.
  Andrew W Campbell> ;Alternative Therapies in Health and Medicine. 2019 Jul 1
• Nathan Bryan, PhD: Addressing the Root of Vascular Disease With Nitric Oxide.
  Andrew W Campbell, Nathan Bryan> ;Alternative Therapies in Health and Medicine. 2018 May 1
• The Epidemic of Obesity.
  Andrew W Campbell> ;Alternative Therapies in Health and Medicine. 2018 Jan 1
• Postprandial Endotoxemia: A Significant Contributor to Chronic Diseases.
  Andrew W Campbell> ;Alternative Therapies in Health and Medicine. 2017 May 1
• Vitamin K2 in the Prevention of Cardiovascular Diseases and Diabetes.
  Andrew W Campbell> ;Alternative Therapies in Health and Medicine. 2017 Jan 15
• 4 citations
  Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice.
  Alexandra Conry, Melissa Peters, Daniel B Fried, Amy Adams, Alfred W Campbell, James D. Bearden, Robert D. Siegel, Howland E. Crosswell> ;Journal of Adolescent and Young Adult Oncology. 2020 Jun 8
• 10 citations
  Meta-analysis of average symptom change in inpatient treatment for posttraumatic stress disorder in veteran and active duty U.S. military samples.
  Justin S. Campbell, George Loeffler, Steven Pulos, Annie W Campbell> ;Psychological Services. 2016 Aug 29
• The Diabetes Pandemic.
  Campbell, A.W.> ;Altern Ther Health Med. 2011-11-01
• Seasonal evaluation of antigenic bacterial infections among working class in the inner city of Houston.
  Anyanwu, E.C., Morad, M., Campbell, A.W.> ;ScientificWorldJournal. 2004 Aug 31
• Metabolism of mycotoxins, intracellular functions of vitamin B12, and neurological manifestations in patients with chronic toxigenic mold exposures. A review.
  Anyanwu, E.C., Morad, M., Campbell, A.W.> ;ScientificWorldJournal. 2004 Aug 26
• Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
  Campbell, A. W., Thrasher, J. D., Madison, R. A., Vojdani, A., Gray, M. R., Johnson, A.> ;Archives of environmental health. 2004 Jul 21
• Efficacy of sodium valproate in the treatment of photosensitive epilepsy (PSE) and the probable reasons for the persistence of occipital spikes.
  Anyanwu, E.C., Ehiri, J.E., Campbell, A.W.> ;ScientificWorldJournal. 2004 Jul 15
• Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments.
  Brasel, T.L., Campbell, A.W., Demers, R.E., Ferguson, B.S., Fink, J., Vojdani, A., Wilson, S.C., Straus, D.C.> ;Arch Environ Health. 2004 Jun
• Mycotoxins and antifungal drug interactions: implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures.
  Anyanwu, E.C., Campbell, A.W., Ehiri, J.E.> ;ScientificWorldJournal. 2004 Mar 12
• Mold and mycotoxins: effects on the neurological and immune systems in humans.
  Campbell, A.W., Thrasher, J.D., Gray, M.R., Vojdani, A.> ;Adv Appl Microbiol. 2004
• The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures.
  Anyanwu, E., Campbell, A.W., Jones, J., Ehiri, J.E., Akpan, A.I.> ;ScientificWorldJournal. 2003 Nov 13
• Biochemical changes in the serum of patients with chronic toxigenic mold exposures: a risk factor for multiple renal dysfunctions.
  Anyanwu, E., Campbell, A.W., Vojdani, A., Ehiri, J.E., Akpan, A.I.> ;ScientificWorldJournal. 2003 Nov 3
• Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
  Vojdani, A., Kashanian, A., Vojdani, E., Campbell, A.W.> ;Immunopharmacol Immunotoxicol. 2003 Nov
• Combination of high-dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.
  Campbell, A.W., Anyanwu, E.C., Vojdani, A.> ;ScientificWorldJournal. 2003 Aug 2
• Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings.
  Vojdani, A., Thrasher, J.D., Madison, R.A., Gray, M.R., Heuser, G., Campbell, A.W.> ;Arch Environ Health. 2003 Jul
• Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings.
  Gray, M.R., Thrasher, J.D., Crago, R., Madison, R.A., Arnold, L., Campbell, A.W., Vojdani, A.> ;Arch Environ Health. 2003 Jul
• Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
  Vojdani, A., Campbell, A.W., Kashanian, A., Vojdani, E.> ;Arch Environ Health. 2003 Jun
• Join now to see all

Journal Articles

• Molds, Mycotoxins, the Brain, the Gut, and Misconceptions  
  Andrew W. Campbell, M.D.; Leonard Weinstock, M.D., Alternative Therapies in Health and Medicine, 3/2022